Advertisement

Nephrology Newsletter

Alpha Blockers for Treatment of Ureteric Stones

Alpha blockers are a class of pharmacological agents that restrict the hormone norepinephrine from tightening the muscles in walls of smaller veins and arteries. The objective of this study is to assess the safety and efficacy...

COVID-19 in Grade 4-5 Chronic Kidney Disease Patients.

Chronic kidney disease (CKD) increases the risk of mortality during coronavirus disease 2019 (COVID-19) episodes, and some reports have underlined the high incidence and severity of this infection in dialysis patients....

Oral Roxadustat in CKD Patients with Anemia

Roxadustat acts as a HIF prolyl-hydroxylase inhibitor and increases the endogenous production of erythropoietin and stimulates the production of hemoglobin in red blood cells. The objective of this study is to evaluate the...

Systolic BP with Risk of Incident CKD

Chronic kidney disease (CKD) and hypertension are closely associated with each other. A few studies suggest that in addition to hypertension, temporal trends in systolic BP could be a potential risk factor of kidney function...

Outcomes of Canagliflozin by Baseline Kidney Function

Canagliflozin is an oral medication that helps control blood sugar levels by helping kidneys get rid of glucose from your bloodstream. Besides, the mediation also aids in reducing cardiovascular and renal events in patients with...

Loading

Advertisement

For latest news and updates
Email-id is invalid

Meeting Coverage